Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite

Extended trastuzumab therapy improves the survival of HER2positive breast cancer patients following surgery and radiotherapy for brain metastases

By                            

Molecular and Clinical Oncology, Vol. 1, Iss. 6, 2013-01 ,pp. : 995-1001

Spandidos Publications

Access to resources Recommend Favorite

Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1062-1068

Spandidos Publications

Access to resources Recommend Favorite

Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications

By Park Daehoon   Kåresen Rolf   Noren Tove   Sauer Torill  

Virchows Archiv, Vol. 451, Iss. 1, 2007-07 ,pp. : 11-18

Springer Publishing Company

Access to resources Recommend Favorite

Survivin, Ki67 and tumor grade as predictors of response to docetaxelbased neoadjuvant chemotherapy in locally advanced breast cancer

By              

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 839-844

Spandidos Publications

Access to resources Recommend Favorite